{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T17:40:29Z","timestamp":1715190029944},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00347-024-02034-4","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T13:02:06Z","timestamp":1714395726000},"page":"374-381","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Staging und Systemtherapie bei okul\u00e4ren und periokul\u00e4ren Metastasen","Staging and systemic treatment of ocular and periocular metastases"],"prefix":"10.1007","volume":"121","author":[{"given":"Daniela","family":"D\u00f6rfel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neele","family":"Babst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwig Maximillian","family":"Heindl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinodh","family":"Kakkassery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin R.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,29]]},"reference":[{"key":"2034_CR1","doi-asserted-by":"publisher","first-page":"FSO871","DOI":"10.2144\/fsoa-2022-0081","volume":"9","author":"A Bader","year":"2023","unstructured":"Bader\u00a0A, Begemann\u00a0M, Al-Obaidi\u00a0A et\u00a0al (2023) Ocular complications of antineoplastic therapies. Future Sci OA 9:FSO871","journal-title":"Future Sci OA"},{"key":"2034_CR2","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s12032-023-02184-6","volume":"40","author":"S Barot","year":"2023","unstructured":"Barot\u00a0S, Patel\u00a0H, Yadav\u00a0A et\u00a0al (2023) Recent advancement in targeted therapy and role of emerging technologies to treat cancer. Med Oncol 40:324","journal-title":"Med Oncol"},{"key":"2034_CR3","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1038\/s41591-022-01935-8","volume":"28","author":"R Bartsch","year":"2022","unstructured":"Bartsch\u00a0R, Berghoff\u00a0AS, Furtner\u00a0J et\u00a0al (2022) Trastuzumab Deruxtecan in HER2-Positive Breast Cancer with Brain Metastases: A\u00a0Single-Arm, Phase\u00a02 Trial. Nat Med 28:1840\u20131847","journal-title":"Nat Med"},{"key":"2034_CR4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1590\/S0004-27492005000200007","volume":"68","author":"ZM Corr\u00e9a","year":"2005","unstructured":"Corr\u00e9a\u00a0ZM, Burmann\u00a0TG, Freitas\u00a0AM et\u00a0al (2005) Prevalence of ocular metastasis in patients with known metastatic disease: preliminary results. Arq Bras Oftalmol 68:189\u2013193","journal-title":"Arq Bras Oftalmol"},{"key":"2034_CR5","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1056\/NEJMoa2115022","volume":"386","author":"J Cort\u00e9s","year":"2022","unstructured":"Cort\u00e9s\u00a0J, Kim\u00a0SB, Chung\u00a0WP et\u00a0al (2022) Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer. N\u00a0Eng J Med 386:1143\u20131154","journal-title":"N Eng J Med"},{"key":"2034_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJMoa2202809","volume":"387","author":"J Cort\u00e9s","year":"2022","unstructured":"Cort\u00e9s\u00a0J, Rugo\u00a0HS, Cescon\u00a0DW et\u00a0al (2022) Pembrolizumab plus Chemotherapy for Triple-Negative Breast Cancer. N\u00a0Eng J Med 387:217\u2013226","journal-title":"N Eng J Med"},{"key":"2034_CR7","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.3390\/cells12242837","volume":"12","author":"M Delgado","year":"2023","unstructured":"Delgado\u00a0M, Garcia-Sanz\u00a0JA (2023) Therapeutic Monoclonal Antibodies against Cancer: Present and Future. Cells 12:2837","journal-title":"Cells"},{"key":"2034_CR8","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S0002-9394(03)00192-2","volume":"136","author":"H Demirci","year":"2003","unstructured":"Demirci\u00a0H, Shields\u00a0CL, Chao\u00a0AN et\u00a0al (2003) Uvela Metastases from Breat Cancer in 264 Patients. Am J Ophthalmol 136:264\u2013271","journal-title":"Am J Ophthalmol"},{"key":"2034_CR9","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/archopht.1974.01010010286003","volume":"92","author":"AP Ferry","year":"1974","unstructured":"Ferry\u00a0AP, Font\u00a0RL (1974) Carcinoma Metastatic to the Eye and Orbit: A\u00a0Clinicopathological Study of 227 Cases. Arch Ophthalmol 92:276\u2013286","journal-title":"Arch Ophthalmol"},{"key":"2034_CR10","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(14)60845-X","volume":"384","author":"EB Garon","year":"2014","unstructured":"Garon\u00a0EB, Ciuleanu\u00a0TE, Arrieta\u00a0O et\u00a0al (2014) Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage\u00a0IV non-smal-cell lung cancer after disease progression on platinum-based therapy (REVEL): a\u00a0multicentre, double-blind, randomised phase\u00a03\u00a0trial. Lancet 384:665\u2013673","journal-title":"Lancet"},{"key":"2034_CR11","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","volume":"372","author":"EB Garon","year":"2015","unstructured":"Garon\u00a0EB, Rizvi\u00a0NA, Hui\u00a0R et\u00a0al (2015) Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer. N\u00a0Eng J Med 372:2018\u201320128","journal-title":"N Eng J Med"},{"key":"2034_CR12","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1097\/IAE.0000000000003459","volume":"42","author":"P Gascon","year":"2022","unstructured":"Gascon\u00a0P, Matet\u00a0A, Gualino\u00a0V et\u00a0al (2022) Clinical Features of Retinal Metastases: New Cases Integrated in a\u00a0Systematic Review of the Literature. Retina 42:1370\u20131383","journal-title":"Retina"},{"key":"2034_CR13","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1056\/NEJMoa1609709","volume":"375","author":"GN Hortobagyi","year":"2016","unstructured":"Hortobagyi\u00a0GN, Stemmer\u00a0SM, Burris\u00a0HA et\u00a0al (2016) Ribociclib as First-Line Therapy for HR-Positive Advanced Breast Cancer. N\u00a0Eng J Med 375:1738\u20131748","journal-title":"N Eng J Med"},{"key":"2034_CR14","first-page":"e46598","volume":"15","author":"N Kelkar","year":"2023","unstructured":"Kelkar\u00a0N, Findakly\u00a0D, Wang\u00a0J (2023) Metastatic Prostate Cancer to the Optic Canal: A\u00a0Large-Cohort Analysis. Cureus 15:e46598","journal-title":"Cureus"},{"key":"2034_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/bjophthalmol-2013-303519","volume":"98","author":"L Konstantinidis","year":"2014","unstructured":"Konstantinidis\u00a0L, Respond-Kubiak\u00a0I, Zeolite\u00a0I et\u00a0al (2014) Management of Patients with Uveal Metastases at The Liverpool Ocular Oncology Centre. Br J Ophthalmol 98:92\u201398","journal-title":"Br J Ophthalmol"},{"key":"2034_CR16","first-page":"208","volume":"6","author":"L Konstantinidis","year":"2017","unstructured":"Konstantinidis\u00a0L, Damato\u00a0B (2017) Intraocular Metastases\u2014A Review. Asia Pac J Ophthalmol 6:208\u2013214","journal-title":"Asia Pac J Ophthalmol"},{"key":"2034_CR17","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1080\/21645515.2021.1885282","volume":"17","author":"X Li","year":"2021","unstructured":"Li\u00a0X, Liang\u00a0Y, Wang\u00a0J et\u00a0al (2021) Pembrolizumab for Choroideal Metastases from Non-Small Cell Lung Cancer: A\u00a0Case Report and Literature Review. Hum Vaccin Immunother 17:2626\u20132629","journal-title":"Hum Vaccin Immunother"},{"key":"2034_CR18","doi-asserted-by":"publisher","first-page":"26102619","DOI":"10.1200\/JCO.20.00775","volume":"38","author":"NU Lin","year":"2020","unstructured":"Lin\u00a0NU, Borges\u00a0V, Anders\u00a0C et\u00a0al (2020) Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial. J\u00a0Clin Oncol 38:26102619","journal-title":"J Clin Oncol"},{"key":"2034_CR19","doi-asserted-by":"publisher","first-page":"1211815","DOI":"10.3389\/fonc.2023.1211815","volume":"13","author":"X Liu","year":"2023","unstructured":"Liu\u00a0X, Chi\u00a0A (2023) Combining stereotactic body radiotherapy with immunotherapy in stage\u00a0IV non-smal cell lung cancer. Front Oncol 13:1211815","journal-title":"Front Oncol"},{"key":"2034_CR20","doi-asserted-by":"publisher","first-page":"e519","DOI":"10.1016\/j.cllc.2022.07.018","volume":"23","author":"B Maller","year":"2022","unstructured":"Maller\u00a0B, Salvatori\u00a0S, Tanvetyanon\u00a0T (2022) Outcomes of Intraocular Metastasis From Lung Cancer in the Era of Targeted Therapy: A\u00a0Systematic Review and Pooled Analysis. Clin Lung Cancer 23:e519\u2013e525","journal-title":"Clin Lung Cancer"},{"key":"2034_CR21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.preteyeres.2018.09.003","volume":"68","author":"T Mathis","year":"2019","unstructured":"Mathis\u00a0T, Jardel\u00a0P, Loria\u00a0O et\u00a0al (2019) New Concepts in the Diagnosis and Management of Choroideal Metastases. Prog Retin Eye Res 68:144\u2013176","journal-title":"Prog Retin Eye Res"},{"key":"2034_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40942-022-00398-w","volume":"8","author":"S Parakh","year":"2022","unstructured":"Parakh\u00a0S, Das\u00a0S, Maheswari\u00a0S et\u00a0al (2022) Regression of Choroideal Metastasis from Breast Carcinoma with Palbociclib. Int J Retin Vitr 8:54\u201359","journal-title":"Int J Retin Vitr"},{"key":"2034_CR23","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1167\/iovs.16-19695","volume":"57","author":"R Parrozzani","year":"2016","unstructured":"Parrozzani\u00a0R, Frizziero\u00a0L, Testi\u00a0L et\u00a0al (2016) Intraocular Metastases Secondary to Breast Carcinoma Correlates with Upregulation of Estrogen and Progesterone Receptor Expression in the Primary Tumor. Invest Ophthalmol Vis Sci 57:3944\u20133948","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2034_CR24","doi-asserted-by":"publisher","first-page":"1296341","DOI":"10.3389\/fimmu.2023.1296341","volume":"14","author":"A Parvez","year":"2023","unstructured":"Parvez\u00a0A, Choudhary\u00a0F, Mudgal\u00a0P et\u00a0al (2023) PD\u20111 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatments. Front Immunol 14:1296341","journal-title":"Front Immunol"},{"key":"2034_CR25","volume-title":"S3-Leitlinie Kolorektales Karzinom","author":"-","year":"2019","unstructured":"- (2019) S3-Leitlinie Kolorektales Karzinom"},{"key":"2034_CR26","volume-title":"S3-Leitlinie Fr\u00fcherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms","author":"-","year":"2021","unstructured":"- (2021) S3-Leitlinie Fr\u00fcherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms"},{"key":"2034_CR27","volume-title":"S3-Leitlinie Pr\u00e4vention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms","author":"-","year":"2023","unstructured":"- (2023) S3-Leitlinie Pr\u00e4vention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms"},{"key":"2034_CR28","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1001\/jamaophthalmol.2016.2627","volume":"134","author":"AW Scott","year":"2016","unstructured":"Scott\u00a0AW, Bressler\u00a0NM, Ffolkes\u00a0S et\u00a0al (2016) Public Attitudes About Eye and Vision Health. JAMA Ophthalmol 134:1111\u20131118","journal-title":"JAMA Ophthalmol"},{"key":"2034_CR29","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1056\/NEJMoa061884","volume":"355","author":"A Sander","year":"2006","unstructured":"Sander\u00a0A, Gray\u00a0R, Perry\u00a0MC et\u00a0al (2006) Paclitaxel-Carboplatin Alone or with Bevacizumab for Non-Small-Cell Lung Cancer. N\u00a0Eng J Med 355:2542\u20132550","journal-title":"N Eng J Med"},{"key":"2034_CR30","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ophtha.2013.07.014","volume":"121","author":"SU Shah","year":"2014","unstructured":"Shah\u00a0SU, Mashayekhi\u00a0A, Shields\u00a0CL et\u00a0al (2014) Uveal Metastases from Lung Cancer: Clinical Features, Treatment, and Outcome in 194 Patients. Ophthalmology 121:352\u2013357","journal-title":"Ophthalmology"},{"key":"2034_CR31","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/S0161-6420(97)30148-1","volume":"104","author":"CL Shields","year":"1997","unstructured":"Shields\u00a0CL, Shields\u00a0JA, Gross\u00a0NE et\u00a0al (1997) Survey of 520 Eyes with Uveal Metastases. Ophthalmology 104:1265\u20131276","journal-title":"Ophthalmology"},{"key":"2034_CR32","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s11864-023-01137-5","volume":"24","author":"M Stanowicki-Grada","year":"2023","unstructured":"Stanowicki-Grada\u00a0M, Senkus\u00a0E (2023) Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer. Curr Treat Options Oncol 24:1633\u20131650","journal-title":"Curr Treat Options Oncol"},{"key":"2034_CR33","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1056\/NEJMoa1413513","volume":"372","author":"SM Swain","year":"2015","unstructured":"Swain\u00a0SM, Baselga\u00a0J, Kim\u00a0SB et\u00a0al (2015) Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer. N\u00a0Eng J Med 372:724\u2013734","journal-title":"N Eng J Med"},{"key":"2034_CR34","doi-asserted-by":"publisher","first-page":"9143","DOI":"10.1186\/1757-1626-2-9143","volume":"2","author":"KI Papageorgiou","year":"2009","unstructured":"Papageorgiou\u00a0KI, Sinha\u00a0A, Ioannidis\u00a0AS et\u00a0al (2009) Ocular metastases from HER2 positive breast carcinoma and the response to the combination therapy with Paclitaxel and Trastuzumab: a\u00a0case report. Cases\u00a0J 2:9143\u20139145","journal-title":"Cases J"},{"key":"2034_CR35","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1159\/000524485","volume":"65","author":"T Tao","year":"2022","unstructured":"Tao\u00a0T, Liu\u00a0Y, Zhang\u00a0J et\u00a0al (2022) Dynamic Observation: Immune-Privileged Microenvironment Limited the Effectiveness of Immunotherapy in an Intraocular Metastasis Mouse Model. Ophthalmic Res 65:584\u2013594","journal-title":"Ophthalmic Res"},{"key":"2034_CR36","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3390\/biomedicines10123044","volume":"10","author":"J Thariat","year":"2022","unstructured":"Thariat\u00a0J, Boudin\u00a0L, Loria\u00a0O et\u00a0al (2022) How to Manage a\u00a0Patient with Ocular Metastases? Biomedicines 10:3044\u20133058","journal-title":"Biomedicines"},{"key":"2034_CR37","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1056\/NEJMoa1209124","volume":"367","author":"S Verma","year":"2012","unstructured":"Verma\u00a0S, Miles\u00a0D, Gianni\u00a0L et\u00a0al (2012) Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer. N\u00a0Eng J Med 367:1783\u20131791","journal-title":"N Eng J Med"},{"key":"2034_CR38","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1007\/s00432-020-03184-z","volume":"146","author":"A Welt","year":"2020","unstructured":"Welt\u00a0A, Bogner\u00a0S, Arendt\u00a0M et\u00a0al (2020) Improved Survival in Metastatic Breast Cancer: Results from a\u00a020-Year Study Involving 1033 Women Treated at a\u00a0Single Comprehensive Cancer Center. J\u00a0Cancer Res Clin Oncol 146:1559\u20131566","journal-title":"J Cancer Res Clin Oncol"},{"key":"2034_CR39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00280-013-2341-4","volume":"73","author":"CJ Yang","year":"2014","unstructured":"Yang\u00a0CJ, Tsai\u00a0YM, Tsai\u00a0MJ et\u00a0al (2014) The Effect of Chemotherapy with Cisplatin and Pemetrexed for Choroideal Metastasis of Non-Squamous Cell Carcinoma. Cancer Chemother Pharmacol 73:199\u2013205","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-024-02034-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-024-02034-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-024-02034-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T17:03:45Z","timestamp":1715187825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-024-02034-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,29]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["2034"],"URL":"https:\/\/doi.org\/10.1007\/s00347-024-02034-4","relation":{},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,29]]},"assertion":[{"value":"7 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"D.\u00a0D\u00f6rfel, N.\u00a0Babst, L.M.\u00a0Heindl, V.\u00a0Kakkassery und M.R.\u00a0M\u00fcller geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}